Eyeing a better 2010, Codexis re-files for IPO

After withdrawing its first attempt at an IPO in September 2008 (citing unfavorable market conditions as its reason), biocatalyst producer Codexis closed out 2009 by filing a new S-1, proposing an initial public offering worth $100 million. Codexis' partners include Merck, Pfizer, Dr. Reddy's Labora...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Dandelion raises $30 million Series B as momentum for the geothermal heating and cooling system startup continues to grow

News Commentary | February 26, 2021

This marks Breakthrough Energy Ventures' first investment since announcing its $1 billion fund in January. Venture capital funding for geothermal startups has sharply fallen since its peak in 2010, but Dandelion joins Eavor as the second geothermal startup to raise funding in 2021, with the two ... Not part of subscription

Grab goes public in largest SPAC deal as merger talks with Gojek fail

News Commentary | April 08, 2021

Several rounds of rumors had suggested Grab and Gojek were nearing a merger. In a turn of events, Grab, Southeast Asia's largest startup, will likely raise more than $2 billion in funding by going public via the SPAC model through Altimeter. Financing from Ant Financial fell through along with the ... To read more, click here.

Ginkgo Bioworks to go public via $17.5 billion SPAC deal

News Commentary | May 13, 2021

Backed by Harry Sloan and Jeff Sagansky, this merger with Soaring Eagle Acquisition will give Ginkgo a pre‑money equity valuation of $15 billion, with an additional $2.5 billion for the combined entity – one of the biggest SPAC deals in recent times. This news comes on the heels of Zymergen's IPO ... To read more, click here.